This book discusses the potential of magnetic nanoparticles in cancer therapy. It reviews the synthesis of magnetic nanoparticles which, due to their small size and processability, have become widely used in various biomedical applications and their role in cancer diagnosis, drug delivery, and personalized medicine. It presents the applications of magnetic nanoparticle in the destruction of tumor cells by heating them to their apoptosis threshold.

It also introduces the new perspective in the development of magnetic field induced drug release in the cancer treatment. Importantly, the book covers the innovative three arm approach in cancer treatment by magnetic nanoparticles through inducing apoptosis, activating the immune response, and targeted-drug delivery.

It highlights various novel approaches to improve the biocompatibility, half-life, and biodegradability of magnetic nanoparticles.

In closing, the book offers comprehensive descriptions of numerous challenges involved in applying magnetic nanoparticles to cancer treatment.

Reviews the application of magnetic nanoparticles in cancer diagnosis and treatment Presents approach to improve the biological properties of magnetic nanoparticles Introduces the three-arm approach for cancer treatment based on magnetic nanoparticles Discusses challenges involved in applying magnetic nanoparticles to cancer therapy

Autorentext

Dr. Raghvendra Ashok Bohara MSc, PhD is a Senior Scientist at CrannMed Ltd., Galway, Ireland, where he leads research and development in biomaterials and embolization medical devices. He previously held prestigious fellowships including the Irish Research Council Postdoctoral Fellowship, the Science Foundation Ireland Fellowship at the University of Galway, and the Indian Council of Medical Research Postdoctoral Fellowship in India. Dr. Bohara's research bridges nanobiotechnology, biomaterials, and cancer drug delivery, with a strong focus on magnetic-triggered systems and cancer nanomedicine. He has authored more than 70 international peer-reviewed publications, and over 80 in total, along with three books and thirteen book chapters, and holds two patents. His work has been cited over ~5000 times (4,075 in the last five years), with an H-index of 38, placing him among the world's top 2% scientists for three consecutive years.

A bridge between academia and industry, Dr. Bohara combines translational research with product-driven innovation. He has mentored numerous Master's and doctoral researchers, actively fostering the next generation of scientists at the interface of academic discovery and industrial application. Beyond his scientific contributions, he serves as Managing Editor for Biomaterials (Elsevier), Associate Editor for Frontiers in Biomaterials Science, and sits on editorial boards of leading journals including Materials Today Bio, Discover Nano, and Scientific Reports . He has also edited volumes with Elsevier, Springer Nature, and IOP Publishing. Dr. Bohara's achievements have been recognized with the Royal Society of Chemistry Highly Cited Author distinction, the Excellence in Research Award (D.Y. Patil University, India), and multiple Young Scientist Travel Fellowships. His career reflects an unwavering commitment to advancing healthcare solutions, mentoring future researchers, and contributing to the global scientific community.

Inhalt

.- Chapter 1: Magnetism in Biomedical Science: Transforming Drug Delivery and Treatment
.- Chapter 2: Cancer: Concepts And Newer Therapies
.- Chapter 3: Magnetic Nanoparticle for Cancer: The Best Approach from Raw
.- Chapter 4: Magnetosome: A Novel Biomolecule in Managing Cancer
.- Chapter 5: Safeguarding The Magnetic Nanoparticle for Enhancing the Biocompatibility, Half-Life, And Biodegradability
.- Chapter 6: Deliver, Induce and Trigger Apoptosis: Three-arm approach to battle against cancer
.- Chapter 7: Current Challenges in Translating Magnetic Nanoparticles in Cancer Therapy Pros and Cons.